Michael D. Lynch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael D. Lynch has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Romel Menacho-Melgar
Department of Biomedical Engineering, Duke University, United States; Roke Biotechnologies, LLC, United States
17 shared publicationsJennifer N. Hennigan
Department of Biomedical Engineering, Duke University, Durham, NC, USA
12 shared publicationsZhixia Ye
Department of Biomedical Engineering, Duke University, Durham, NC, USA
12 shared publicationsEirik A. Moreb
Department of Biomedical Engineering, Duke University, Durham, NC, USA
11 shared publicationsShuai Li
Department of Chemistry Duke University Durham North Carolina USA
11 shared publicationsUtsuki Yano
Department of Chemistry Duke University Durham North Carolina USA
10 shared publications
Latest Publications
- 28 October 2026
- Published by Wiley in Biotechnology Journal
- Vol. 21 (11) , e70329
Improved Biosynthesis of Ethylene Glycol From Xylose in Engineered E. coli Utilizing Two‐Stage Dynamic Control
We engineered Escherichia coli for improved ethylene glycol (EG) biosynthesis using two‐stage dynamic metabolic control coupled with pathway optimization. An engineered Dahms pathway ( xylB, xylC, xylD, yqhD ) was induced upon phosphate depletion to enable EG biosynthesis during stationary phase. The performance of our initial strain, expressing a baseline pathway, was improved by the addition of “stoichiometric” valves enabling proteolytic degradation of xylose isomerase and soluble transhydrogenase, upon phosphate depletion. Reduction of these enzymes, which compete for substrates with EG biosynthesis, led to a 3‐fold increase in specific productivity. In contrast, enabling “regulatory” dynamic metabolic valves targeting enoyl‐ACP reductase and glucose‐6‐phosphate dehydrogenase, designed to enhance NADPH flux, did not improve production in this control. Following pathway optimization, regulatory strains exhibited enhanced production rates exceeding 0.5 g gCDW − 1 h − 1 , a 14‐fold improvement over the control, while stoichiometric valves conferred no benefit. Scale‐up in fed‐batch bioreactors achieved 140 g L − 1 EG in 70 h with a yield of 0.38 g g − 1 xylose (92% of theoretical), representing one of the highest reported titers in E. coli . These results demonstrate that optimal engineering strategies shift with pathway capacity. While elimination of competing fluxes benefits low‐flux systems, high‐flux pathways require enhanced cofactor regeneration.
- 28 October 2026
- Published by Wiley in Biotechnology Journal
- Vol. 21 (11) , e70329
Improved Biosynthesis of Ethylene Glycol From Xylose in Engineered E. coli Utilizing Two‐Stage Dynamic Control
We engineered Escherichia coli for improved ethylene glycol (EG) biosynthesis using two‐stage dynamic metabolic control coupled with pathway optimization. An engineered Dahms pathway ( xylB, xylC, xylD, yqhD ) was induced upon phosphate depletion to enable EG biosynthesis during stationary phase. The performance of our initial strain, expressing a baseline pathway, was improved by the addition of “stoichiometric” valves enabling proteolytic degradation of xylose isomerase and soluble transhydrogenase, upon phosphate depletion. Reduction of these enzymes, which compete for substrates with EG biosynthesis, led to a 3‐fold increase in specific productivity. In contrast, enabling “regulatory” dynamic metabolic valves targeting enoyl‐ACP reductase and glucose‐6‐phosphate dehydrogenase, designed to enhance NADPH flux, did not improve production in this control. Following pathway optimization, regulatory strains exhibited enhanced production rates exceeding 0.5 g gCDW − 1 h − 1 , a 14‐fold improvement over the control, while stoichiometric valves conferred no benefit. Scale‐up in fed‐batch bioreactors achieved 140 g L − 1 EG in 70 h with a yield of 0.38 g g − 1 xylose (92% of theoretical), representing one of the highest reported titers in E. coli . These results demonstrate that optimal engineering strategies shift with pathway capacity. While elimination of competing fluxes benefits low‐flux systems, high‐flux pathways require enhanced cofactor regeneration.
- 26 September 2026
- Published by Elsevier in Bioresource Technology
- Vol. 464 (Pt B) , 135959
Efficient Myoinositol biosynthesis from glucose through gluconate bypass of glycolysis
- 26 September 2026
- Published by Elsevier in Bioresource Technology
- Vol. 464 (Pt B) , 135959
Efficient Myoinositol biosynthesis from glucose through gluconate bypass of glycolysis
- 25 July 2026
- Published by Elsevier in Metabolic Engineering
- Vol. 98
Engineering a gluconate bypass carbon entry architecture for robust stationary phase biomanufacturing
- 25 July 2026
- Published by Elsevier in Metabolic Engineering
- Vol. 98
Engineering a gluconate bypass carbon entry architecture for robust stationary phase biomanufacturing
- 3 April 2026
- Published by Elsevier in Trends in Biotechnology
- Vol. 44 (11) , 3235-3249
Recent advances in systems engineering approaches to integrated strain and bioprocess development
- 3 April 2026
- Published by Elsevier in Trends in Biotechnology
- Vol. 44 (11) , 3235-3249
Recent advances in systems engineering approaches to integrated strain and bioprocess development
- Open Access
Improved Biosynthesis of Ethylene Glycol from Xylose in Engineered E. coli Utilizing Two-Stage Dynamic Control
In this study, we employ a two-stage dynamic metabolic control strategy to enhance the NADPH dependent biosynthesis of ethylene glycol from xylose in engineered E. coli . We evaluated the use of metabolic valves to dynamically reduce the enzymes involved in competitive pathways which compete for substrates with ethylene glycol biosynthesis, as well as regulatory pathways aimed at increasing NADPH fluxes. The performance of our initial strains with limits in pathway expression levels was improved by the addition of competitive valves, but not by increases in NADPH flux. In contrast, improving pathway expression levels, led to strains improved significantly by our regulatory valves which improved NADPH flux, but not by the competitive valves. This is consistent with a central hypothesis that faster pathways in and of themselves can compete with other metabolic fluxes by being faster and are better aided by regulatory changes capable of change rates elsewhere in metabolism. In this case in NADPH flux. Lastly, upon scale up to fed-batch bioreactors, our optimized strain, featuring dynamic control of two regulatory valves produced 140 g/L of EG in 70 hours at 92% of the theoretical yield.
Open AccessImproved Biosynthesis of Ethylene Glycol from Xylose in Engineered E. coli Utilizing Two-Stage Dynamic Control
In this study, we employ a two-stage dynamic metabolic control strategy to enhance the NADPH dependent biosynthesis of ethylene glycol from xylose in engineered E. coli . We evaluated the use of metabolic valves to dynamically reduce the enzymes involved in competitive pathways which compete for substrates with ethylene glycol biosynthesis, as well as regulatory pathways aimed at increasing NADPH fluxes. The performance of our initial strains with limits in pathway expression levels was improved by the addition of competitive valves, but not by increases in NADPH flux. In contrast, improving pathway expression levels, led to strains improved significantly by our regulatory valves which improved NADPH flux, but not by the competitive valves. This is consistent with a central hypothesis that faster pathways in and of themselves can compete with other metabolic fluxes by being faster and are better aided by regulatory changes capable of change rates elsewhere in metabolism. In this case in NADPH flux. Lastly, upon scale up to fed-batch bioreactors, our optimized strain, featuring dynamic control of two regulatory valves produced 140 g/L of EG in 70 hours at 92% of the theoretical yield.
- Open Access
Decoupling Central Metabolism from Catabolite Repression Enables Robust Cellulosic Sugar Co-consumption in E. coli
Lignocellulosic biomass is the most abundant and sustainable carbon source for bioproduction, but its efficient utilization is hampered by the heterogeneous mixture of sugars released upon hydrolysis. Most industrial strains consume these mixed sugars sequentially due to strong regulation and cross-inhibition, leading to complex processes and reduced carbon efficiency. To address this, we leverage a novel central metabolism that decouples central carbon flux from native regulatory feedback by employing a Gluconate-Bypass of glycolysis. We demonstrate that the Gluconate-Bypass effectively alleviates feedback regulation in E. coli, enabling co-consumption of glucose and xylose. Further strain engineering leads to the first robust co-utilization of four major lignocellulosic sugars: glucose, xylose, arabinose, and galactose. By decoupling central carbon flux from native regulatory feedback, this architecture provides a feedstock-agnostic platform that maintains high and robust consumption regardless of extreme fluctuations in sugar composition.
Open AccessDecoupling Central Metabolism from Catabolite Repression Enables Robust Cellulosic Sugar Co-consumption in E. coli
Lignocellulosic biomass is the most abundant and sustainable carbon source for bioproduction, but its efficient utilization is hampered by the heterogeneous mixture of sugars released upon hydrolysis. Most industrial strains consume these mixed sugars sequentially due to strong regulation and cross-inhibition, leading to complex processes and reduced carbon efficiency. To address this, we leverage a novel central metabolism that decouples central carbon flux from native regulatory feedback by employing a Gluconate-Bypass of glycolysis. We demonstrate that the Gluconate-Bypass effectively alleviates feedback regulation in E. coli, enabling co-consumption of glucose and xylose. Further strain engineering leads to the first robust co-utilization of four major lignocellulosic sugars: glucose, xylose, arabinose, and galactose. By decoupling central carbon flux from native regulatory feedback, this architecture provides a feedstock-agnostic platform that maintains high and robust consumption regardless of extreme fluctuations in sugar composition.
- Open Access
Engineering Orthogonal Carbon Dissimilation: A Gluconate Bypass Platform for Robust Stationary-Phase Biomanufacturing
Two-stage bioprocesses which decouple cell growth from product synthesis are an attractive approach to biomanufacturing. However high levels of production in stationary phase cultures often suffer from a progressive decline in metabolism. We demonstrate that in E. coli pyruvate accumulation, an inevitable consequence of high-flux metabolism, acts as a major inhibitor of stationary-phase glucose uptake. We present a novel central metabolism to optimize stationary phase production, a gluconate-bypass, which circumvents this challenge by rerouting carbon flux around glycolysis. This redesign achieves two critical outcomes: first, it decouples glucose uptake from pyruvate inhibition; second, glucose oxidation intrinsically co-generates the NADPH cofactor. Validated using NADPH-dependent L-alanine as a representative model, the GBP creates a self-regulating host that achieved a record titer of 197 g/L with a 1.6-fold extension of production longevity. This work establishes the GBP as a generalizable platform for robust stationary phase biosynthesis.
Open AccessEngineering Orthogonal Carbon Dissimilation: A Gluconate Bypass Platform for Robust Stationary-Phase Biomanufacturing
Two-stage bioprocesses which decouple cell growth from product synthesis are an attractive approach to biomanufacturing. However high levels of production in stationary phase cultures often suffer from a progressive decline in metabolism. We demonstrate that in E. coli pyruvate accumulation, an inevitable consequence of high-flux metabolism, acts as a major inhibitor of stationary-phase glucose uptake. We present a novel central metabolism to optimize stationary phase production, a gluconate-bypass, which circumvents this challenge by rerouting carbon flux around glycolysis. This redesign achieves two critical outcomes: first, it decouples glucose uptake from pyruvate inhibition; second, glucose oxidation intrinsically co-generates the NADPH cofactor. Validated using NADPH-dependent L-alanine as a representative model, the GBP creates a self-regulating host that achieved a record titer of 197 g/L with a 1.6-fold extension of production longevity. This work establishes the GBP as a generalizable platform for robust stationary phase biosynthesis.
- 26 July 2025
- Published by Elsevier in Bioresource Technology
- Vol. 436, 133034
Instant enzymes: Systems engineering approach to rapid low cost production of thermostable molecular biology enzymes
- 26 July 2025
- Published by Elsevier in Bioresource Technology
- Vol. 436, 133034
Instant enzymes: Systems engineering approach to rapid low cost production of thermostable molecular biology enzymes
- 24 July 2024
- Published by Elsevier in Metabolic Engineering
- Vol. 85, 116-130
Scalable, robust, high-throughput expression & purification of nanobodies enabled by 2-stage dynamic control
- 24 July 2024
- Published by Elsevier in Metabolic Engineering
- Vol. 85, 116-130
Scalable, robust, high-throughput expression & purification of nanobodies enabled by 2-stage dynamic control
- 23 April 2024
- Published by Wiley in Biotechnology Journal
- Vol. 19 (4) , 2400005
Phase separation methods for protein purification: A meta‐analysis of purification performance and cost‐effectiveness
Protein purifications based on phase separations (e.g., precipitation and liquid‐liquid extraction) have seen little adoption in commercial protein drug production. To identify barriers, we analyzed the purification performance and economics of 290 phase separation purifications from 168 publications. First, we found that studies using Design of Experiments for optimization achieved significantly greater mean yield and host cell protein log10 removal values than those optimizing one factor at a time (11.5% and 53% increases, respectively). Second, by modeling each reported purification at scales from 10 to 10,000 kg product/year and comparing its cost‐effectiveness versus chromatography, we found that cost‐effectiveness depends strongly on scale: the fraction of phase separations predicted to be cost‐effective at the 10, 100, and 1000 kg/year scales was 8%, 15%, and 43%, respectively. Total cost per unit product depends inversely on input purity, with phase separation being cheaper than chromatography at the 100 kg/year scale in 100% of cases where input purity was ≤ 1%, compared to about 25% of cases in the dataset as a whole. Finally, we identified a simple factor that strongly predicts phase separation process costs: the mass ratio of reagents versus purified product (the “direct materials usage rate”), which explains up to 58% of variation in cost per unit of purified product among all 290 reports, and up to 98% of variation within particular types of phase separation.
- 23 April 2024
- Published by Wiley in Biotechnology Journal
- Vol. 19 (4) , 2400005
Phase separation methods for protein purification: A meta‐analysis of purification performance and cost‐effectiveness
Protein purifications based on phase separations (e.g., precipitation and liquid‐liquid extraction) have seen little adoption in commercial protein drug production. To identify barriers, we analyzed the purification performance and economics of 290 phase separation purifications from 168 publications. First, we found that studies using Design of Experiments for optimization achieved significantly greater mean yield and host cell protein log10 removal values than those optimizing one factor at a time (11.5% and 53% increases, respectively). Second, by modeling each reported purification at scales from 10 to 10,000 kg product/year and comparing its cost‐effectiveness versus chromatography, we found that cost‐effectiveness depends strongly on scale: the fraction of phase separations predicted to be cost‐effective at the 10, 100, and 1000 kg/year scales was 8%, 15%, and 43%, respectively. Total cost per unit product depends inversely on input purity, with phase separation being cheaper than chromatography at the 100 kg/year scale in 100% of cases where input purity was ≤ 1%, compared to about 25% of cases in the dataset as a whole. Finally, we identified a simple factor that strongly predicts phase separation process costs: the mass ratio of reagents versus purified product (the “direct materials usage rate”), which explains up to 58% of variation in cost per unit of purified product among all 290 reports, and up to 98% of variation within particular types of phase separation.